These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 35484638)

  • 1. Circulating bile acid concentrations and non-alcoholic fatty liver disease in Guatemala.
    Rivera-Andrade A; Petrick JL; Alvarez CS; Graubard BI; Florio AA; Kroker-Lobos MF; Parisi D; Freedman ND; Lazo M; Guallar E; Groopman JD; Ramirez-Zea M; McGlynn KA
    Aliment Pharmacol Ther; 2022 Jul; 56(2):321-329. PubMed ID: 35484638
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potent suppression of hydrophobic bile acids by aldafermin, an FGF19 analogue, across metabolic and cholestatic liver diseases.
    Sanyal AJ; Ling L; Beuers U; DePaoli AM; Lieu HD; Harrison SA; Hirschfield GM
    JHEP Rep; 2021 Jun; 3(3):100255. PubMed ID: 33898959
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum bile acid level and fatty acid composition in Chinese children with non-alcoholic fatty liver disease.
    Lu LP; Wan YP; Xun PC; Zhou KJ; Chen C; Cheng SY; Zhang MZ; Wu CH; Lin WW; Jiang Y; Feng HX; Wang JL; He K; Cai W
    J Dig Dis; 2017 Aug; 18(8):461-471. PubMed ID: 28585279
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pegbelfermin selectively reduces secondary bile acid concentrations in patients with non-alcoholic steatohepatitis.
    Luo Y; Decato BE; Charles ED; Shevell DE; McNaney C; Shipkova P; Apfel A; Tirucherai GS; Sanyal AJ
    JHEP Rep; 2022 Jan; 4(1):100392. PubMed ID: 34977519
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bile acids associate with specific gut microbiota, low-level alcohol consumption and liver fibrosis in patients with non-alcoholic fatty liver disease.
    Adams LA; Wang Z; Liddle C; Melton PE; Ariff A; Chandraratna H; Tan J; Ching H; Coulter S; de Boer B; Christophersen CT; O'Sullivan TA; Morrison M; Jeffrey GP
    Liver Int; 2020 Jun; 40(6):1356-1365. PubMed ID: 32243703
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intestinal aberrant sphingolipid metabolism shaped-gut microbiome and bile acids metabolome in the development of hepatic steatosis.
    Miao RR; Zhan S; Cui SX; Qu XJ
    FASEB J; 2022 Aug; 36(8):e22398. PubMed ID: 35792869
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gender-Specific Bile Acid Profiles in Non-Alcoholic Fatty Liver Disease.
    Fitzinger J; Rodriguez-Blanco G; Herrmann M; Borenich A; Stauber R; Aigner E; Mangge H
    Nutrients; 2024 Jan; 16(2):. PubMed ID: 38257143
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NASH-related increases in plasma bile acid levels depend on insulin resistance.
    Grzych G; Chávez-Talavera O; Descat A; Thuillier D; Verrijken A; Kouach M; Legry V; Verkindt H; Raverdy V; Legendre B; Caiazzo R; Van Gaal L; Goossens JF; Paumelle R; Francque S; Pattou F; Haas JT; Tailleux A; Staels B
    JHEP Rep; 2021 Apr; 3(2):100222. PubMed ID: 33615207
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative profiling of 19 bile acids in rat plasma, liver, bile and different intestinal section contents to investigate bile acid homeostasis and the application of temporal variation of endogenous bile acids.
    Yang T; Shu T; Liu G; Mei H; Zhu X; Huang X; Zhang L; Jiang Z
    J Steroid Biochem Mol Biol; 2017 Sep; 172():69-78. PubMed ID: 28583875
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Investigation of chemical profile of bile acids and determination of them in cultured Bovis Calculus with UPLC-QDA].
    Yan S; Feng W; Bao-Jun L; Yan-Fang J; Nan C; Fang-Fang D; Shuang-Cheng MA
    Zhongguo Zhong Yao Za Zhi; 2020 Nov; 45(21):5232-5237. PubMed ID: 33350240
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bile acids profile, histopathological indices and genetic variants for non-alcoholic fatty liver disease progression.
    Nimer N; Choucair I; Wang Z; Nemet I; Li L; Gukasyan J; Weeks TL; Alkhouri N; Zein N; Tang WHW; Fischbach MA; Brown JM; Allayee H; Dasarathy S; Gogonea V; Hazen SL
    Metabolism; 2021 Mar; 116():154457. PubMed ID: 33275980
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum bile acid patterns are associated with the presence of NAFLD in twins, and dose-dependent changes with increase in fibrosis stage in patients with biopsy-proven NAFLD.
    Caussy C; Hsu C; Singh S; Bassirian S; Kolar J; Faulkner C; Sinha N; Bettencourt R; Gara N; Valasek MA; Schnabl B; Richards L; Brenner DA; Hofmann AF; Loomba R
    Aliment Pharmacol Ther; 2019 Jan; 49(2):183-193. PubMed ID: 30506692
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bile Acids and Dysbiosis in Non-Alcoholic Fatty Liver Disease.
    Mouzaki M; Wang AY; Bandsma R; Comelli EM; Arendt BM; Zhang L; Fung S; Fischer SE; McGilvray IG; Allard JP
    PLoS One; 2016; 11(5):e0151829. PubMed ID: 27203081
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Simultaneous determination of nine kinds of dominating bile acids in various snake bile by ultrahigh-performance liquid chromatography with triple quadrupole linear iontrap mass spectrometry.
    Zhang J; Fan Y; Gong Y; Chen X; Wan L; Zhou C; Zhou J; Ma S; Wei F; Chen J; Nie J
    J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Nov; 1068-1069():245-252. PubMed ID: 29129604
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum metabolome and targeted bile acid profiling reveals potential novel biomarkers for drug-induced liver injury.
    Ma Z; Wang X; Yin P; Wu R; Zhou L; Xu G; Niu J
    Medicine (Baltimore); 2019 Aug; 98(31):e16717. PubMed ID: 31374067
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hyperoside attenuates non-alcoholic fatty liver disease in rats via cholesterol metabolism and bile acid metabolism.
    Wang S; Sheng F; Zou L; Xiao J; Li P
    J Adv Res; 2021 Dec; 34():109-122. PubMed ID: 35024184
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disease-Associated Gut Microbiota Reduces the Profile of Secondary Bile Acids in Pediatric Nonalcoholic Fatty Liver Disease.
    Yu J; Zhang H; Chen L; Ruan Y; Chen Y; Liu Q
    Front Cell Infect Microbiol; 2021; 11():698852. PubMed ID: 34568090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conjugated bile acids promote ERK1/2 and AKT activation via a pertussis toxin-sensitive mechanism in murine and human hepatocytes.
    Dent P; Fang Y; Gupta S; Studer E; Mitchell C; Spiegel S; Hylemon PB
    Hepatology; 2005 Dec; 42(6):1291-9. PubMed ID: 16317705
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The association of serum total bile acid with non-alcoholic fatty liver disease in Chinese adults: a cross sectional study.
    Zhang Z; Dai W; Weng S; Luo M; Fu J; Zadroga JA; Spolitu S; Peng D
    Lipids Health Dis; 2020 Feb; 19(1):18. PubMed ID: 32019569
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    Sun C; Qiu C; Zhang Y; Yan M; Tan J; He J; Yang D; Wang D; Wu L
    Molecules; 2023 May; 28(10):. PubMed ID: 37241783
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.